Mostrar el registro sencillo del ítem

Analysis of Immunotherapy in hepatocellular carcinoma

dc.contributor.authorBurgos-Molina, Antonio Manuel 
dc.contributor.authorAlamilla Presuel, Juan Carlos
dc.contributor.authorGonzález Vidal, Alejandro
dc.contributor.authorRuiz-Gómez, Miguel José 
dc.date.accessioned2023-01-11T12:48:41Z
dc.date.available2023-01-11T12:48:41Z
dc.date.created2023
dc.date.issued2022
dc.identifier.urihttps://hdl.handle.net/10630/25714
dc.description.abstractOne reason immunotherapy is important for Hepatocellular carcinoma, it’s because there are many immune cells in that organ. Because HCC is very aggressive, immunotherapy must be applied correctly. There are a lot of immunotherapies for all cancers, nevertheless, some has been tested for specific organs or tissues, and probably in the future, this organ-specific treatments can be applied in other tumor tissues.es_ES
dc.description.sponsorshipUniversidad de Málaga. Campus de Excelencia Internacional Andalucía Tech.es_ES
dc.language.isoenges_ES
dc.publisherAseicaes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectInmunoterapia - Congresoses_ES
dc.subjectCancer - Congresoses_ES
dc.subject.otherImmunotherapyes_ES
dc.subject.otherHepatocellular cancer.es_ES
dc.titleAnalysis of Immunotherapy in hepatocellular carcinomaes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.centroFacultad de Medicinaes_ES
dc.relation.eventtitle18th ASEICA INTERNATIONAL CONGRESSes_ES
dc.relation.eventplaceSantiago de Compostela, España.es_ES
dc.relation.eventdate16 al 18 de Noviembre 2022es_ES
dc.rights.ccAttribution-NonCommercial-NoDerivatives 4.0 Internacional*


Ficheros en el ítem

Nombre:
15- Burgos Molina AM. Analysis ...
Tamaño:
265.1Kb
Formato:
PDF

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional